JP2023539990A5 - - Google Patents
Info
- Publication number
- JP2023539990A5 JP2023539990A5 JP2023502702A JP2023502702A JP2023539990A5 JP 2023539990 A5 JP2023539990 A5 JP 2023539990A5 JP 2023502702 A JP2023502702 A JP 2023502702A JP 2023502702 A JP2023502702 A JP 2023502702A JP 2023539990 A5 JP2023539990 A5 JP 2023539990A5
- Authority
- JP
- Japan
- Prior art keywords
- dotaga
- euk
- sub
- lutetium
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063051335P | 2020-07-13 | 2020-07-13 | |
| US63/051,335 | 2020-07-13 | ||
| US202163143664P | 2021-01-29 | 2021-01-29 | |
| US63/143,664 | 2021-01-29 | ||
| PCT/IB2021/000467 WO2022013610A2 (en) | 2020-07-13 | 2021-07-13 | Radiopharmaceutical and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539990A JP2023539990A (ja) | 2023-09-21 |
| JP2023539990A5 true JP2023539990A5 (https=) | 2024-07-22 |
Family
ID=79171978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502702A Pending JP2023539990A (ja) | 2020-07-13 | 2021-07-13 | 放射性薬剤および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11491246B2 (https=) |
| EP (1) | EP4178628A4 (https=) |
| JP (1) | JP2023539990A (https=) |
| KR (1) | KR20240004205A (https=) |
| AU (1) | AU2021309907A1 (https=) |
| BR (1) | BR112023000763A2 (https=) |
| CA (1) | CA3185565A1 (https=) |
| IL (1) | IL299760A (https=) |
| MX (1) | MX2023000623A (https=) |
| TW (1) | TW202216205A (https=) |
| WO (1) | WO2022013610A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4178628A4 (en) | 2020-07-13 | 2025-04-02 | Point Biopharma, Inc. | RADIOPHARMACEUTICALS AND PROCEDURES |
| JP2025505307A (ja) * | 2022-03-02 | 2025-02-21 | ポイント・バイオファーマ・インコーポレイテッド | 放射性医薬品及び方法 |
| CN114404619A (zh) * | 2022-03-28 | 2022-04-29 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其制备方法和用途 |
| CN114404618A (zh) * | 2022-03-28 | 2022-04-29 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其用途 |
| WO2023215333A1 (en) * | 2022-05-02 | 2023-11-09 | Point Biopharma, Inc. | Radiopharmaceutical and methods |
| CN115015441B (zh) * | 2022-07-14 | 2023-08-18 | 原子高科股份有限公司 | 一种测定镥[177Lu]氧奥曲肽注射液中稳定剂含量的方法 |
| CN119630434A (zh) * | 2022-07-18 | 2025-03-14 | 库瑞姆美国有限责任公司 | 用于靶向分子成像的铜的放射性药物组合物 |
| CA3263646A1 (en) * | 2022-07-29 | 2024-07-18 | Curium Us Llc | [177lu] lutetium-psma l&t composition, kit, method of making, and method of using thereof |
| EP4568985A1 (en) * | 2022-08-11 | 2025-06-18 | Advancell Isotopes Pty Limited | Radiopharmaceuticals |
| TW202426433A (zh) | 2022-09-23 | 2024-07-01 | 瑞士商紐利迪姆股份公司 | 成纖維細胞活化蛋白（ｆａｐ）抑制劑、ｆａｐ結合物及其診斷與治療用途 |
| KR20250073273A (ko) | 2022-09-23 | 2025-05-27 | 누클리디움 아게 | 고순도 구리 방사성 의약 조성물 및 이의 진단 및 치료 용도 |
| WO2024121722A1 (en) | 2022-12-05 | 2024-06-13 | Novartis Ag | Method of treating prostate cancer |
| MX2025012292A (es) * | 2023-04-14 | 2026-02-03 | Fusion Pharmaceuticals Inc | Terapia de combinación con inhibidores de la respuesta al daño de adn y radiofármacos dirigidos a psma |
| KR20260035965A (ko) | 2023-07-11 | 2026-03-13 | 노파르티스 아게 | 전립선암의 치료 방법 |
| CN121604981A (zh) | 2023-07-21 | 2026-03-03 | 诺华公司 | 靶向psma的放射性配体治疗方案 |
| WO2025029946A1 (en) * | 2023-07-31 | 2025-02-06 | Curium Us Llc | [177lu] lutetium-psma i&t composition and dosimetry, kit, method of making, and method of using thereof |
| US12514939B2 (en) | 2024-02-14 | 2026-01-06 | Alpha-9 Oncology, Inc. | Stable radiopharmaceutical compositions and uses thereof |
| WO2025235951A1 (en) * | 2024-05-09 | 2025-11-13 | Curium Us Llc | Radiopharmaceutical compositions for actinium in targeted radionuclide therapy |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005001415A2 (en) * | 2003-05-23 | 2005-01-06 | Epix Pharmaceuticals, Inc. | Optically pure and enriched isomers of chelating ligands and contrast agents |
| JP5139678B2 (ja) | 2003-07-24 | 2013-02-06 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | 安定な放射性医薬品組成物およびその製法 |
| WO2016149188A1 (en) | 2015-03-13 | 2016-09-22 | The Johns Hopkins University | 68Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTS |
| EP3456700A1 (en) | 2013-10-18 | 2019-03-20 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| CN106660943B (zh) | 2014-05-06 | 2020-03-17 | 约翰霍普金斯大学 | 用于psma靶向的成像和放射疗法的金属/放射性金属标记的psma抑制物 |
| WO2018108287A1 (en) | 2016-12-15 | 2018-06-21 | The European Atomic Energy Community (Euratom), Represented By The European Commission | Treatment of pmsa expressing cancers |
| CN111032632B (zh) | 2017-05-30 | 2024-04-12 | 约翰霍普金斯大学 | 用于前列腺癌的腔内放射疗法的前列腺特异性膜抗原靶向的高亲和力剂 |
| US10596276B2 (en) | 2018-07-25 | 2020-03-24 | Advanced Accelerator Applications (Italy) S.R.L. | Stable, concentrated radionuclide complex solutions |
| US10596278B2 (en) * | 2018-07-25 | 2020-03-24 | Advanced Accelerator Applications (Italy) S.R.L. | Stable, concentrated radionuclide complex solutions |
| IL281600B2 (en) | 2018-09-21 | 2026-03-01 | Endocyte Inc | Cancer treatment methods |
| WO2020064693A1 (en) | 2018-09-25 | 2020-04-02 | Advanced Accelerator Applications (Italy) Srl | Combination therapy |
| EA202191691A1 (ru) * | 2019-01-30 | 2021-11-01 | Технише Универзитет Мюнхен | Радиоактивная метка, связывающая psma двумя способами, и терапевтическое средство |
| US11129912B1 (en) * | 2020-07-13 | 2021-09-28 | POINT Biopharma Inc. | Radiopharmaceutical and methods |
| EP4178628A4 (en) | 2020-07-13 | 2025-04-02 | Point Biopharma, Inc. | RADIOPHARMACEUTICALS AND PROCEDURES |
| CA3190855A1 (en) | 2020-08-27 | 2022-03-03 | Joe Mccann | Radiopharmaceutical and methods |
| WO2022111800A1 (en) | 2020-11-25 | 2022-06-02 | Itm Solucin Gmbh | Stable formulations for radionuclide complexes |
| CN118695876A (zh) | 2021-11-29 | 2024-09-24 | 普安生物制药有限公司 | 放射性药物治疗方法和用途 |
-
2021
- 2021-07-13 EP EP21841476.1A patent/EP4178628A4/en active Pending
- 2021-07-13 US US17/374,984 patent/US11491246B2/en active Active
- 2021-07-13 IL IL299760A patent/IL299760A/en unknown
- 2021-07-13 AU AU2021309907A patent/AU2021309907A1/en active Pending
- 2021-07-13 CA CA3185565A patent/CA3185565A1/en active Pending
- 2021-07-13 JP JP2023502702A patent/JP2023539990A/ja active Pending
- 2021-07-13 KR KR1020237004275A patent/KR20240004205A/ko not_active Withdrawn
- 2021-07-13 BR BR112023000763A patent/BR112023000763A2/pt not_active Application Discontinuation
- 2021-07-13 WO PCT/IB2021/000467 patent/WO2022013610A2/en not_active Ceased
- 2021-07-13 MX MX2023000623A patent/MX2023000623A/es unknown
- 2021-07-13 TW TW110125666A patent/TW202216205A/zh unknown
- 2021-09-27 US US17/486,875 patent/US20220016274A1/en not_active Abandoned
-
2022
- 2022-09-22 US US17/934,450 patent/US20230302163A1/en active Pending
-
2023
- 2023-04-17 US US18/135,595 patent/US12558440B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023539990A5 (https=) | ||
| DE2748132C2 (https=) | ||
| JP5589130B1 (ja) | 結晶及び該結晶を含有してなる医薬製剤 | |
| JP5453559B1 (ja) | 晶癖を有する結晶及び該結晶を加工してなる医薬組成物 | |
| JPH0725789B2 (ja) | フランカルボン酸モメタゾン―水和物、その製造法および医薬組成物 | |
| US2803582A (en) | Local anesthetic composition | |
| JP2023540240A5 (https=) | ||
| JPS6321648B2 (https=) | ||
| DE3530046A1 (de) | Aethylendiaminmonoamid-derivate | |
| JP2020511440A5 (https=) | ||
| JPH01500191A (ja) | 向骨性テクネチウム‐９９ｍ錯体 | |
| CN110845408A (zh) | 同位素富集的乐伐替尼 | |
| DE2617895A1 (de) | Dispersion zur herstellung eines injizierbaren radiopharmazeutischen scanning-mittels | |
| KR102295585B1 (ko) | 새로운 미네랄 주사제 조성물 | |
| WO2025016240A1 (zh) | 一种含环磺酮除草组合物的制备方法 | |
| US4053570A (en) | Aluminum halohydrate | |
| JP5698395B2 (ja) | 結晶及び該結晶を含有してなる医薬製剤 | |
| EP3057571A1 (en) | Proton pump inhibitor paste compositions | |
| CN109431996B (zh) | 一种含米诺地尔的外用剂组合物及其制备方法 | |
| EP0209511B1 (fr) | Chlorhydrates de chlorures de dérivés d'aminoalkyl-2 hydroxy-9 ellipticinium et compositions pharmaceutiques en contenant | |
| JP4630586B2 (ja) | 歯質再石灰化促進剤 | |
| JPS5828844B2 (ja) | カ−バメ−トの安定化方法 | |
| JPH0233013B2 (ja) | Sokonchiryozai | |
| US2007786A (en) | Process for stabilization of calcium gluconate solutions | |
| JPS59164713A (ja) | 真珠光沢付与剤 |